![](/img/cover-not-exists.png)
A pilot study of antithymocyte globulin (ATG) in the treatment of patients with ‘low-risk’ myelodysplasia
Sally B. Killick, Ghulam Mufti, Jamie D. Cavenagh, Alex Mijovic, Janet L. Peacock, Edward C. Gordon-Smith, David T. Bowen, Judith C. W. MarshVolume:
120
Year:
2003
Language:
english
Pages:
6
DOI:
10.1046/j.1365-2141.2003.04136.x
File:
PDF, 82 KB
english, 2003